Related Experiment Videos
Current issues in hypertension. Old questions with new answers and new questions
1Alton Ochsner Medical Foundation, New Orleans, Louisiana.
Insights
Hypertension, a vascular disease, impacts heart, brain, and kidneys. Lowering blood pressure mitigates risks to these organs, though questions remain regarding heart and kidney protection.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Neurology
Background:
- Hypertension is a systemic vascular disease affecting target organs like the heart, brain, and kidneys.
- Increased vascular resistance is a hallmark, leading to left ventricular hypertrophy and increased morbidity/mortality.
- Therapeutic reduction of arterial pressure mitigates associated risks.
Purpose of the Study:
- To explore the mechanisms behind hypertension's impact on target organs.
- To investigate why protective effects on the brain are more pronounced than on the heart.
- To address the rising incidence of end-stage renal disease despite therapy.
Main Methods:
- Review of clinical and experimental evidence.
- Analysis of hemodynamic factors in hypertension.
- Examination of therapeutic outcomes on target organs.
Main Results:
- Arterial pressure reduction reverses risks to target organs, including stroke.
- Evidence suggests differing impacts of combined hypertensive and atherosclerotic disease on heart vs. brain.
- An increase in end-stage renal disease is observed despite widespread hypertension therapy.
Conclusions:
- Hypertension management reduces risks, but specific organ protection varies.
- Further research is needed to understand differential effects on the heart and brain.
- The rising prevalence of end-stage renal disease requires urgent investigation.
Abstract:
Hypertension is a systemic vascular disease that makes its mark upon the "target organs"--heart, brain, and kidneys--through the hemodynamic hallmark of the disease, a progressively increasing vascular resistance to the forward flow of blood. The effect of pressure overload upon the heart is one of concentric hypertrophy of the left ventricle that is, in turn, associated with an independent risk of morbidity and mortality. Reduction of arterial pressure reverses the risk associated with the elevated arterial pressure and also diminishes the risk from hemorrhagic and thrombotic strokes. Why the risk of the interaction of hypertensive and atherosclerotic diseases can be reduced on the brain but not as impressively on the heart remains to be learned, but certain recent lines of clinical and experimental evidence point to some answers. The issue as to why, in the face of increasing numbers of patients receiving the benefits of therapy, there is an alarming increase in patients with end-stage renal disease defies more imagination and study. Thus, many of the old questions seem to be achieving some meaningful answers; but associated with these new answers we are confronted with new questions.